Evidence map›Paper›PMID 41749833›Full record

ReviewCancers2026

Burkitt Lymphoma-A Guide to Biological Features, Diagnosis and Differential Diagnosis.

Ioannis Anagnostopoulos, Alberto Zamò, Heike Horn, Annette Staiger, German Ott

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ioannis AnagnostopoulosInstitute of Pathology, University of Würzburg, 97080 Würzburg, Germany.ORCID 0000-0002-5043-6043
Alberto ZamòInstitute of Pathology, University of Würzburg, 97080 Würzburg, Germany.ORCID 0000-0001-6203-7966
Heike HornDepartment of Clinical Pathology, Robert-Bosch-Hospital, 70376 Stuttgart, Germany.ORCID 0000-0002-2933-005X
Annette StaigerDepartment of Clinical Pathology, Robert-Bosch-Hospital, 70376 Stuttgart, Germany.ORCID 0000-0002-5896-3200
German OttDepartment of Clinical Pathology, Robert-Bosch-Hospital, 70376 Stuttgart, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Burkitt lymphoma (BL) is an aggressive mature B-cell lymphoma that represents one of the most studied human malignancies. Initially described in equatorial Africa by the Irish surgeon Denis P. Burkitt, African (endemic) Burkitt lymphoma was the first human neoplasm shown to be associated with a virus, the Epstein-Barr virus (EBV), and also the first human neoplasm shown to harbor a recurrent chromosomal aberration, the t(8;14) (q24;q32) translocation that led to the identification of the central role of the

Indexed as

11q aberrationB-lymphoblastic leukemia/lymphomaBurkitt lymphomadiffuse large B-cell lymphomaEpstein-Barr virushigh-grade B-cell lymphomaMYC rearrangement

Identifiers

PMID41749833
PMCPMC12938643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.